Jul 13, 2026 08:04AM
Jul 13, 2026 08:01AM
Jun 29, 2026 08:03AM
Jun 29, 2026 08:01AM
Jun 1, 2026 08:01AM
Jun 1, 2026 08:00AM
May 13, 2026 06:02AM Voyager presents positive safety data for Alzheimer's gene therapy VY1706
May 13, 2026 06:01AM
May 7, 2026 04:01PM
Mar 9, 2026 04:01PM
Nov 10, 2025 08:01AM
May 6, 2025 04:01PM
Mar 31, 2025 07:01AM
Mar 31, 2025 07:00AM Voyager Presents Robust Preclinical Data from Tau Targeting Gene Therapy and Antibody Programs at AD/PD™ 2025
Nov 20, 2024 07:00AM
Aug 20, 2024 06:44AM
Aug 6, 2024 04:01PM
May 13, 2024 04:01PM
Apr 16, 2024 07:02AM
Apr 16, 2024 07:00AM
Dec 6, 2023 07:05AM Voyager Therapeutics (VYGR) Announces Selection of Development Candidate for SOD1 Amyotrophic Lateral Sclerosis Gene Therapy Program
Dec 6, 2023 07:00AM
Aug 3, 2023 07:00AM
May 9, 2023 07:00AM
Jan 9, 2023 07:44AM
Jan 9, 2023 07:00AM
Sep 7, 2022 07:33AM
Sep 7, 2022 07:30AM Voyager Therapeutics Appoints Peter Pfreundschuh as CFO; Todd Carter, Ph.D., as Chief Scientific Officer; and Trista Morrison as SVP Corporate Affairs
Aug 4, 2022 04:01PM
May 4, 2022 04:01PM
Mar 8, 2022 06:16AM
May 10, 2021 07:30AM
Apr 26, 2021 08:06AM
Apr 26, 2021 08:00AM
Feb 25, 2021 04:01PM Voyager Therapeutics Announces Fourth Quarter and Full Year 2020 Financial Results and Corporate Updates
Feb 22, 2021 10:48AM
Feb 19, 2021 01:00PM
Feb 2, 2021 04:02PM
Feb 2, 2021 04:01PM
Dec 23, 2020 08:56AM
Dec 22, 2020 04:20PM
Dec 22, 2020 04:17PM Voyager Therapeutics Provides Update on NBIb-1817 (VY-AADC) Gene Therapy Program
Nov 9, 2020 04:00PM
Oct 13, 2020 09:27AM
Oct 12, 2020 05:21PM
Oct 12, 2020 04:04PM
Oct 12, 2020 04:01PM
Sep 11, 2020 11:36AM
Sep 11, 2020 11:33AM Neurocrine Bio (NBIX), Voyager (VYGR) Present New L-T 3-Year Data Demonstrating that One-Time Treatment with Investigational Gene Therapy Showed Sustained Improvement in Motor Function
Sep 11, 2020 11:32AM

325,591 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All